Pyrroles
Medchemexpress LLC HY-16925 2mg Medchemexpress, MI-503 CAS:1857417-13-0 Purity:>98%
Medchemexpress, HY-16925 2mg MI-503 CAS:1857417-13-0 MI-503 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC HY-122243 5mg Medchemexpress, IU1-47 CAS:670270-31-2 Purity:>98%
Medchemexpress, HY-122243 5mg IU1-47 CAS:670270-31-2 IU1-47 is a potent and specific USP14 inhibitor with an IC 50 of 0.6 μM. IU1-47 inhibits IsoT/USP5 with an IC 50 of 20 μM. IU1-47 induces tau elimination in cultured neurons [1] . Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC HY-13402 5mg Medchemexpress, Varespladib CAS:172732-68-2 Purity:>98%
Medchemexpress, HY-13402 5mg Varespladib CAS:172732-68-2 Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC Varespladib methyl | 172733-08-3 | 99.9% | 394.42 | 100 MG
Varespladib methyl is a selective inhibitor of group II secretory phospholipase A2 (PLA2). It is an orally-administered methyl ester pro-drug that is metabolized to LY315920.
- Selective inhibitor of group II secretory phospholipase A2 (PLA2)
- Orally-administered methyl ester pro-drug
- High-level secretory PLA2 (sPLA2) inhibition at nanomolar and picomolar concentrations
- White to off-white solid appearance
- Intended for research use only
Medchemexpress LLC HY-112842 10mg Medchemexpress, MBQ-167 CAS:2097938-73-1 Purity:>98%
Medchemexpress, HY-112842 10mg MBQ-167 CAS:2097938-73-1 MBQ-167 is a dual Rac/Cdc42 inhibitor, with IC50s of 103 nM for Rac 1/2/3 and 78 nM for Cdc42 in MDA-MB-231 cells, respectively. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Medchemexpress LLC Kw-8232 | 217813-15-5 | 98.1% | 705.26 g/mol | C37H41ClN4O6S | 50 MG
KW-8232 is an orally active anti-osteoporotic small molecule that reduces prostaglandin E2 (PGE2) biosynthesis in osteoblastic cells and has reported antiviral activity against SARS-CoV-2 (EC50 ≈1.2 μM). Supplied as a solid for research use with reported high purity and recommended storage conditions.
Medchemexpress LLC HY-101746 5mg Medchemexpress, GSK376501A CAS:1010412-80-2 Purity:>98%
Medchemexpress, HY-101746 5mg GSK376501A CAS:1010412-80-2 GSK376501A is a selective peroxisome proliferator-activated receptor gamma (PPARγ) modulator for the treatment of type 2 diabetes mellitus. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
eMolecules 211813-86-4 | Medchem Express | Eniporide hydrochloride | 5mg | 446258943 | HY-106150B | 356.83 | C14H17ClN4O3S
Ambeed | 7-(Diethylamino)-4-(trifluoromethyl)-2H-chromen-2-one | 250mg | 686016108 | A407743 | 41934-47-8 | MFCD00057313 | 285.266 | C14H14F3NO2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC Pamicogrel | 101001-34-7 | 448.53 | 50 MG
Pamicogrel is a cyclooxygenase (COX) inhibitor. It possesses platelet anti-aggregatory properties and is being developed for chronic arterial occlusion. This compound also demonstrates potential in the prophylaxis and treatment of ischemic brain injury.
- Cyclooxygenase inhibitor
- Exhibits platelet anti-aggregatory properties
- Under development for chronic arterial occlusion
- Shows potential in prophylaxis and treatment of ischemic brain injury